Literature DB >> 26265857

Optical coherence tomography in the management of posterior scleritis.

Avadhesh Oli1, D Joshi2.   

Abstract

Entities:  

Keywords:  Optical coherence tomography; Posterior scleritis; Steroids

Year:  2014        PMID: 26265857      PMCID: PMC4529585          DOI: 10.1016/j.mjafi.2014.09.012

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


× No keyword cloud information.
  7 in total

1.  Posterior scleritis associated with systemic tuberculosis.

Authors:  Amit Gupta; Vishali Gupta; Surinder S Pandav; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2003-12       Impact factor: 1.848

2.  Enhanced depth imaging optical coherence tomography of the choroid in recurrent unilateral posterior scleritis.

Authors:  Wakako Taki; Hiroshi Keino; Takayo Watanabe; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-07       Impact factor: 3.117

3.  [Posterior scleritis: clinical features, systemic association, treatment and evolution of 23 patients].

Authors:  Danuza de Oliveira Machado; André Luis Land Curi; Thaís Fontes Bessa; Wesley Ribeiro Campos; Fernando Oréfice
Journal:  Arq Bras Oftalmol       Date:  2009 May-Jun       Impact factor: 0.872

4.  Posterior scleritis: ultrasound findings in two cases.

Authors:  P Perri; V Mazzeo; P De Palma; B Pastena; G Police; L Ravalli; A Rossi
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

5.  Intravitreal bevacizumab (avastin) as an adjuvant for the treatment of posterior scleritis.

Authors:  Ji Won Lim; Joo Hyun Park
Journal:  Korean J Ophthalmol       Date:  2011-07-22

6.  Optical coherence tomography findings in a child with posterior scleritis.

Authors:  H Erdol; M Kola; A Turk
Journal:  Eur J Ophthalmol       Date:  2008 Nov-Dec       Impact factor: 2.597

7.  Posterior scleritis: a clinical and histological survey.

Authors:  C M Calthorpe; P G Watson; A C McCartney
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.